Compounds > cci 103f
Page last updated: 2024-09-03

cci 103f and Uterine Cervical Neoplasms

cci 103f has been researched along with Uterine Cervical Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bennewith, KL; Durand, RE; Raleigh, JA1
Bennewith, KL; Durand, RE1

Other Studies

2 other study(ies) available for cci 103f and Uterine Cervical Neoplasms

ArticleYear
Orally administered pimonidazole to label hypoxic tumor cells.
    Cancer research, 2002, Dec-01, Volume: 62, Issue:23

    Topics: Administration, Oral; Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Flow Cytometry; Humans; Male; Mice; Mice, SCID; Neoplasm Transplantation; Nitroimidazoles; Transplantation, Heterologous; Tumor Cells, Cultured; Uterine Cervical Neoplasms

2002
Quantifying transient hypoxia in human tumor xenografts by flow cytometry.
    Cancer research, 2004, Sep-01, Volume: 64, Issue:17

    Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Colonic Neoplasms; Female; Flow Cytometry; Humans; Mice; Mice, SCID; Nitroimidazoles; Oxygen; Partial Pressure; Transplantation, Heterologous; Uterine Cervical Neoplasms

2004